WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LGND earnings and revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

LGND Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when LGND announces earnings.

LGND Return on Assets

Current Company
N/A
Current Industry
2.9%

LGND Return on Capital Employed

Current Company
0%
Current Industry
19.5%

LGND vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LGNDN/AN/AN/AN/AN/A
VRNA$0.00-$51.16M-$54.37M-100.00%N/A
KNSA$301.77M-$16.36M$8.65M+106.55%-95.74%
SLNO$0.00-$36.71M-$38.99MN/AN/A
XNCR$168.34M-$108.78M-$126.09M+32.90%N/A
View Top Biotech Stocks

LGND earnings dates

Next earnings date
Jun 14, 2024

Ligand Pharmaceuticals Earnings & Revenue FAQ

What were LGND's earnings last quarter?

On Invalid Date, Ligand Pharmaceuticals (NASDAQ: LGND) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Ligand Pharmaceuticals earnings for the quarter were N/A. In the same quarter last year, Ligand Pharmaceuticals's earnings per share (EPS) was -$1.04.

If you're new to stock investing, here's how to buy Ligand Pharmaceuticals stock.

What was LGND's earnings growth in the past year?

As of Q2 2024, Ligand Pharmaceuticals's earnings has grown year over year. Ligand Pharmaceuticals's earnings in the past year totalled N/A.

What is LGND's earnings date?

Ligand Pharmaceuticals's earnings date is Invalid Date. Add LGND to your watchlist to be reminded of LGND's next earnings announcement.

What was LGND's revenue last quarter?

On Invalid Date, Ligand Pharmaceuticals (NASDAQ: LGND) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Ligand Pharmaceuticals's revenue was $27.05 million.

What was LGND's revenue growth in the past year?

As of Q2 2024, Ligand Pharmaceuticals's revenue has grown null year over year. Ligand Pharmaceuticals's revenue in the past year totalled N/A.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.